Sign In
Buy WEIGF
Weir Group Earnings Calls
| Release date | Mar 04, 2026 |
| EPS estimate | $0.90 |
| EPS actual | $0.88 |
| EPS Surprise | -2.88% |
| Revenue estimate | 1.872B |
| Revenue actual | 1.846B |
| Revenue Surprise | -1.42% |
| Release date | Jul 31, 2025 |
| EPS estimate | $0.795 |
| EPS actual | $0.80 |
| EPS Surprise | 0.88% |
| Revenue estimate | 1.735B |
| Revenue actual | 1.64B |
| Revenue Surprise | -5.47% |
| Release date | Apr 25, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Feb 26, 2025 |
| EPS estimate | $0.82 |
| EPS actual | $0.94 |
| EPS Surprise | 15.44% |
| Revenue estimate | 1.713B |
| Revenue actual | 1.624B |
| Revenue Surprise | -5.17% |
Last 4 Quarters for Weir Group
Below you can see how WEIGF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 26, 2025 |
| Price on release | $28.97 |
| EPS estimate | $0.82 |
| EPS actual | $0.94 |
| EPS surprise | 15.44% |
| Date | Price |
|---|---|
| Feb 20, 2025 | $28.97 |
| Feb 21, 2025 | $28.97 |
| Feb 24, 2025 | $28.97 |
| Feb 25, 2025 | $28.97 |
| Feb 26, 2025 | $28.97 |
| Feb 27, 2025 | $28.97 |
| Feb 28, 2025 | $28.97 |
| Mar 03, 2025 | $28.97 |
| Mar 04, 2025 | $28.97 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Apr 25, 2025 |
| Price on release | $29.67 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Apr 21, 2025 | $29.67 |
| Apr 22, 2025 | $29.67 |
| Apr 23, 2025 | $29.67 |
| Apr 24, 2025 | $29.67 |
| Apr 25, 2025 | $29.67 |
| Apr 28, 2025 | $29.67 |
| Apr 29, 2025 | $30.00 |
| Apr 30, 2025 | $30.00 |
| May 01, 2025 | $30.00 |
| 4 days before | 0% |
| 4 days after | 1.11% |
| On release day | 0% |
| Change in period | 1.11% |
| Release date | Jul 31, 2025 |
| Price on release | $35.20 |
| EPS estimate | $0.795 |
| EPS actual | $0.80 |
| EPS surprise | 0.88% |
| Date | Price |
|---|---|
| Jul 25, 2025 | $36.60 |
| Jul 28, 2025 | $36.60 |
| Jul 29, 2025 | $35.20 |
| Jul 30, 2025 | $35.20 |
| Jul 31, 2025 | $35.20 |
| Aug 01, 2025 | $36.60 |
| Aug 04, 2025 | $35.20 |
| Aug 05, 2025 | $36.60 |
| Aug 06, 2025 | $32.30 |
| 4 days before | -3.83% |
| 4 days after | -8.24% |
| On release day | 0% |
| Change in period | -11.75% |
| Release date | Mar 04, 2026 |
| Price on release | $48.94 |
| EPS estimate | $0.90 |
| EPS actual | $0.88 |
| EPS surprise | -2.88% |
| Date | Price |
|---|---|
| Feb 26, 2026 | $48.94 |
| Feb 27, 2026 | $48.94 |
| Mar 02, 2026 | $48.94 |
| Mar 03, 2026 | $48.94 |
| Mar 04, 2026 | $48.94 |
| Mar 05, 2026 | $48.94 |
| Mar 06, 2026 | $48.94 |
| Mar 09, 2026 | $48.94 |
| Mar 10, 2026 | $48.94 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Weir Group Earnings Call Transcript Summary of Q4 2025
Weir delivered a strong 2025 with 6% constant-currency revenue growth to GBP 2.6bn, a 15% increase in adjusted operating profit to GBP 518m and operating margins expanding 150bps to 20.2% (achieving the 20% target a year early). Orders grew 7% to GBP 2.6bn with aftermarket up 8% and OE stable (brownfield demand). Free operating cash conversion was 92% and net debt/EBITDA rose to 1.9x after self-funded acquisitions (Micromine, Townley, Fast2Mine) and a strategic investment in CiDRA, with management targeting deleveraging back to ~0.5–1.5x by end-2026. Scope 1 & 2 emissions are down 31% vs 2019, ahead of targets. Strategic progress: creation of a software-led mining solutions platform (Micromine, Motion Metrics, Fast2Mine), geographic expansion (Townley, Chile JV completion), new product launches (ENDURON VSM, NEXT-generation pumps) and a higher cumulative Performance Excellence savings target of GBP 90m (GBP 59m achieved to date). Guidance and outlook for 2026: mid-single-digit revenue growth, further margin expansion of ~50bps, free operating cash conversion of 90–100%, around GBP 90m net interest cost, CapEx ~1.3x depreciation (including SAP S/4 rollout), and an effective tax rate ~28%. Key near-term risks/notes: timing of large greenfield projects remains uncertain (could drive upside but timing is unclear), legacy asbestos entity has been deconsolidated with management stating provisions are sufficient, working capital elevated in 2025 (targeting normalization in 2026), and continued investment in R&D/IT will partly offset margin gains.
